rasagiline has been researched along with nisoxetine in 1 studies
| Studies (rasagiline) | Trials (rasagiline) | Recent Studies (post-2010) (rasagiline) | Studies (nisoxetine) | Trials (nisoxetine) | Recent Studies (post-2010) (nisoxetine) |
|---|---|---|---|---|---|
| 535 | 72 | 314 | 316 | 2 | 62 |
| Protein | Taxonomy | rasagiline (IC50) | nisoxetine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0079 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.0079 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.4 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0131 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.8628 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Fuster, MJ; García-Sevilla, JA | 1 |
1 other study(ies) available for rasagiline and nisoxetine
| Article | Year |
|---|---|
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |